Aimmune Therapeutics (NASDAQ: AIMT) Acquisition
Aimmune Therapeutics (AIMT) Acquisition
Nestlé (NSRGY) and Aimmune Therapeutics (AIMT) $2.6bn acquisition information including expected completion date, offer price and contact details are displayed in the acquisition details table…
